EMIIL - Non-interventional study to investigate the effectiveness of Emicizumab under
real-world conditions in pediatric, adolescent, adult and elderly patients with hemophilia
A (PwHA) with and without FVIII inhibitors: an interim analysis
Autoren
J Oldenburg
1
University of Bonn, Bonn, Germany
C Escuriola-Ettingshausen
2
Haemophilia Centre Rhine Main (HZRM), Mörfelden-Walldorf, Germany
P Fontana
3
University Hospitals of Geneva, Division of Angiology and Haemostasis, Geneva, Switzerland
4
University of Geneva, Geneva Platelet Group, Faculty of Medicine, Geneva, Switzerland
S Wenning
5
SRH Kurpfalzkrankenhaus, Heidelberg, Germany
C Pfrepper
6
University Hospital Leipzig, Division of Hemostaseology, Leipzig, Germany
B Heidersdorf
7
Roche Pharma AG, Grenzach, Germany
P Udvardi
8
Roche Pharma Schweiz, Basel, Switzerland
M Albisetti
9
University Children’s Hospital, Hematology Department, Zürich, Switzerland
